Business Standard

US begins first human trial of coronavirus vaccine: statement

Image

AFP Washington

The first human trial to evaluate a candidate vaccine against coronavirus disease 2019 has begun in Seattle, US health officials said Monday.

"The open-label trial will enroll 45 healthy adult volunteers ages 18 to 55 years over approximately 6 weeks," the US National Institutes of Health (NIH) said in a statement.

"The first participant received the investigational vaccine today.

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Mar 16 2020 | 11:28 PM IST

Explore News